Uveitis Withdrawn Phase 2 Trials for Sirolimus (DB00877)

Also known as: Unspecified iridocyclitis / Uveitis NOS / Uveitis (disorder)

IndicationStatusPhase
DBCOND0009937 (Uveitis)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01280669Intravitreal Sirolimus as Therapeutic Approach to UveitisTreatment